Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease
Clinical trial NCT02337517 · TERMINATED
Trial details
- NCT number
- NCT02337517
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-08
- Primary completion
- 2018-06-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.